Search Results - "Mourits, M. P."

Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' Orbitopathy by Bartalena, L, Krassas, G. E, Wiersinga, W, Marcocci, C, Salvi, M, Daumerie, C, Bournaud, C, Stahl, M, Sassi, L, Veronesi, G, Azzolini, C, Boboridis, K. G, Mourits, M. P, Soeters, M. R, Baldeschi, L, Nardi, M, Currò, N, Boschi, A, Bernard, M, von Arx, G, for the European Group on Graves' Orbitopathy

“…Background: Optimal doses of iv glucocorticoids for Graves' orbitopathy (GO) are undefined. Methods: We carried out a multicenter, randomized, double-blind…”
Get full text

Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial by Wakelkamp, I. M. M. J., Baldeschi, L., Saeed, P., Mourits, M. P., Prummel, M. F., Wiersinga, W. M.

“…Summary Objective  Only a small percentage of Graves’ ophthalmopathy (GO) patients develop optic neuropathy with impending loss of visual acuity. Therapy with…”
Get full text

Outcome of orbital decompression for disfiguring proptosis in patients with Graves' orbitopathy using various surgical procedures by Mourits, M P, Bijl, H, Altea, M A, Baldeschi, L, Boboridis, K, Currò, N, Dickinson, A J, Eckstein, A, Freidel, M, Guastella, C, Kahaly, G J, Kalmann, R, Krassas, G E, Lane, C M, Lareida, J, Marcocci, C, Marino, M, Nardi, M, Mohr, Ch, Neoh, C, Pinchera, A, Orgiazzi, J, Pitz, S, Saeed, P, Salvi, M, Sellari-Franceschini, S, Stahl, M, von Arx, G, Wiersinga, W M

“…To compare the outcome of various surgical approaches of orbital decompression in patients with Graves' orbitopathy (GO) receiving surgery for disfiguring…”
Get more information

Clinical assessment of patients with Graves’ orbitopathy: the European Group on Graves’ Orbitopathy recommendations to generalists, specialists and clinical researchers by Wiersinga, W M, Perros, P, Kahaly, G J, Mourits, M P, Baldeschi, L, Boboridis, K, Boschi, A, Dickinson, A J, Kendall-Taylor, P, Krassas, G E, Lane, C M, Lazarus, J H, Marcocci, C, Marino, M, Nardi, M, Neoh, C, Orgiazzi, J, Pinchera, A, Pitz, S, Prummel, M F, Sartini, M S, Stahl, M, von Arx, G

Get full text

Straylight Measurements in Two Different Apodized Diffractive Multifocal Intraocular Lenses by Lapid-Gortzak, Ruth, Labuz, Grzegorz, van der Meulen, Ivanka J, van der Linden, Jan Willem, Mourits, M P, van den Berg, Tom J

“…To evaluate differences in straylight between eyes implanted with a hydrophilic multifocal IOL (Seelens MF; Hanita Lenses, Hanita, Israel) and a hydrophobic…”
Get more information

Optimal management of Graves orbitopathy: a multidisciplinary approach by SOETERS, M. R, VAN ZEIJL, C. J. J, BOELEN, A, KLOOS, R, SAEED, P, VRIESENDORP, T. M, MOURITS, M. P

“…Graves' thyroid disease is a relatively common disorder in endocrinology and general internal medicine practice. Graves' hyperthyroidism is mediated by…”
Get full text

Interpretation and validity of changes in scores on the Graves' ophthalmopathy quality of life questionnaire (GO-QOL) after different treatments by Terwee, C. B., Dekker, F. W., Mourits, M.P., Gerding, M. N., Baldeschi, L., Kalmann, R., Prummel, M. F., Wiersinga, W. M.

“…The Graves' ophthalmopathy quality of life questionnaire (GO‐QOL) is the first instrument available to measure health‐related quality of life (HRQL) of…”
Get full text

Soluble IL‐2 receptor levels in patients with Graves’ophthalmopathy by PRUMMEL, M. F, WIERSINGA, W. M., GAAG, R., MOURITS, M. P, KOORNNEEF, L.

“…SUMMARY In various autoimmune diseases circulating levels of soluble 1L‐2 receptor (sIL‐2R) seem to be related to disease activity. Because reliable parameters…”
Get full text

Sensor-based intervention to enhance movement control of the spine in low back pain: Protocol for a quasi-randomized controlled trial by Mourits, Bianca M. P., Vos, Lammert A., Bruijn, Sjoerd M., Dieën, Jaap H. van, Prins, Maarten R.

“…Introduction Chronic low back pain is a common condition that imposes an enormous burden on individuals and society. Physical exercise with education is the…”
Get full text

A questionnaire survey on the management of Graves’ orbitopathy in Europe by Perros, P, Baldeschi, L, Boboridis, K, Dickinson, A J, Hullo, A, Kahaly, G J, Kendall-Taylor, P, Krassas, G E, Lane, C M, Lazarus, J H, Marcocci, C, Marino, M, Mourits, M P, Nardi, M, Orgiazzi, J, Pinchera, A, Pitz, S, Prummel, M F, Wiersinga, W M

“…Objective: To determine management patterns among clinicians who treat patients with Graves’ orbitopathy (GO) in Europe. Design and methods: Questionnaire…”
Get full text

Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study by Mourits, Maarten P, van Kempen-Harteveld, M Loes, García, M Begoña García, Koppeschaar, Hans PF, Tick, Lidwine, Terwee, Caroline B

“…The best treatment (steroids, irradiation, or both) for moderately severe Graves' orbitopathy, a self-limiting disease is not known. We tested the efficacy of…”
Get full text

Prevalence and management of elevated intraocular pressure in patients with Graves’ orbitopathy by Kalmann, Rachel, Mourits, Maarten Ph

“…AIMS To investigate the prevalence and to discuss the necessity of treating elevated intraocular pressures (IOP) in patients with Graves’ orbitopathy (GO). In…”
Get full text

Diabetes mellitus: a risk factor in patients with Graves’ orbitopathy by Kalmann, Rachel, Mourits, Maarten Ph

“…AIMS To assess the prevalence of dysthyroid optic neuropathy (DON) in patients with diabetes mellitus (DM) and Graves’ orbitopathy (GO) and to investigate the…”
Get full text

Controversies in orbital reconstruction—II. Timing of post-traumatic orbital reconstruction: A systematic review by Dubois, L, Steenen, S.A, Gooris, P.J.J, Mourits, M.P, Becking, A.G

“…Abstract The timing of orbital reconstruction is a determinative factor with respect to the incidence of potential postoperative orbital complications. In…”
Get full text

Controversies in orbital reconstruction—I. Defect-driven orbital reconstruction: A systematic review by Dubois, L, Steenen, S.A, Gooris, P.J.J, Mourits, M.P, Becking, A.G

“…Abstract In the 1980s, computed tomography was introduced as an imaging modality for diagnosing orbital fractures. Since then, new light has been shed on the…”
Get full text

Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves’ orbitopathy? by Bartalena, L., Veronesi, G., Krassas, G. E., Wiersinga, W. M., Marcocci, C., Marinò, M., Salvi, M., Daumerie, C., Bournaud, C., Stahl, M., Sassi, L., Azzolini, C., Boboridis, K. G., Mourits, M. P., Soeters, M. R., Baldeschi, L., Nardi, M., Currò, N., Boschi, A., Bernard, M., von Arx, G., Perros, P., Kahaly, G. J.

“…Purpose Intravenous glucocorticoids (ivGCs) given as 12-weekly infusions are the first-line treatment for moderate-to-severe and active Graves’ orbitopathy…”
Get full text

Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach by Mourits, M P, Koornneef, L, Wiersinga, W M, Prummel, M F, Berghout, A, van der Gaag, R

“…Patients with serious inflammatory Graves' ophthalmopathy should be treated with anti-inflammatory drugs or radiotherapy to prevent complications like…”
Get full text

A single technique to correct various degrees of upper lid retraction in patients with Graves’ orbitopathy by Mourits, Maarten Ph, Sasim, Inna Vladimirovna

“…BACKGROUND Several lengthening techniques have been proposed for upper eyelid retraction in patients with Graves’ orbitopathy and variable rates of success…”
Get full text

Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy by Prummel, M F, Mourits, M P, Blank, L, Berghout, A, Koornneef, L, Wiersinga, W M

“…Corticosteroids are usually given for management of Graves' ophthalmopathy, but they have many and serious side-effects. By comparison, retrobulbar irradiation…”
Get more information

Clinical features of dysthyroid optic neuropathy: a European Group on Graves’ Orbitopathy (EUGOGO) survey by McKeag, David, Lane, Carol, Lazarus, John H, Baldeschi, Lelio, Boboridis, Kostas, Dickinson, A Jane, Hullo, A Iain, Kahaly, George, Krassas, Gerry, Marcocci, Claudio, Marinò, Michele, Mourits, Maarten P, Nardi, Marco, Neoh, Christopher, Orgiazzi, Jacques, Perros, Petros, Pinchera, Aldo, Pitz, Susanne, Prummel, Mark F, Sartini, Maria S, Wiersinga, Wilmar M

“…Background: This study was performed to determine clinical features of dysthyroid optic neuropathy (DON) across Europe. Methods: Forty seven patients with DON…”
Get full text